Basis: FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.
The P/S ratio is N/A as of 2026-10-06T14:21:19.043Z.
Calculation as of: 2026-10-06T14:21:19.043Z.
Quote observation: 2026-10-06T14:19:52.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 0fde8dae4c5ae63ee7b35c7e6e46bba2fdf5d6d5db310b32cf0eb41a7e17e840
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
PS RATIO
N/A
Market Cap
$83.89M
PS Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$82.35M
PS Ratio
13.30
TTM Avg
5.23
3Y Avg
5.24
5Y Avg
18.61
Market Cap
$85.55M
PS Ratio
168.41
TTM Avg
221.52
3Y Avg
228.25
5Y Avg
248.51
| NAME | MARKET CAP | PS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Conexeu Sciences Inc. (CNXU) | $84.98M | N/A | N/A | N/A | N/A |
| Humacyte, Inc. (HUMA)vs › | $84.03M | 39.62 | 49.38 | 546.61 | 880.05 |
| Acrivon Therapeutics, Inc. Common Stock (ACRV)vs › | $83.89M | N/A | N/A | N/A | N/A |
| MediciNova, Inc. (MNOV)vs › | $83.18M | 90.37 | 216.46 | 165.81 | 579.35 |
| Cognition Therapeutics, Inc. (CGTX)vs › | $84.20M | N/A | N/A | N/A | N/A |
| Citius Oncology, Inc. (CTOR)vs › | $81.83M | 11.52 | 16.63 | 16.63 | 16.63 |
| Atara Biotherapeutics, Inc. (ATRA)vs › | $82.35M | 13.30 | 5.23 | 5.24 | 18.61 |
| Cardiff Oncology, Inc. (CRDF)vs › | $85.55M | 168.41 | 221.52 | 228.25 | 248.51 |
| CareCloud, Inc. (CCLD)vs › | $86.90M | 0.68 | 0.94 | 0.55 | 0.51 |
| LENSAR Inc (LNSR)vs › | $81.98M | 1.36 | 2.06 | 1.84 | 1.67 |
The four-quarter calculation detail is unavailable for this stored observation.
The current P/S calculation cannot be reconciled from the stored quote and revenue inputs.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
P/S Ratio
N/A
Market Cap / Trailing Twelve-Month Revenue
PS Ratio = Market Cap / Revenue (TTM)
The price-to-sales ratio compares market capitalization to trailing revenue. It is useful for valuing companies with little or no earnings.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
